Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model.

Files

Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability A discrete-event simulation(1).pdf (656.59 KB)

Date

2016

Type:

Artículo

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

92

Vistas totales

0
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier B.V.

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

http://hdl.handle.net/11447/931
 http://dx.doi.org/ 10.1016/j.jns.2016.04.005

item.page.extent

item.page.accessRights

item.page.other

item.page.references

Abstract

BACKGROUND: The only pharmacological treatment with proven cost-effectiveness in reducing acute ischemic stroke (AIS) associated disability is intravenous thrombolysis with recombinant tissue plasmin...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Hoffmeister L, Lavados PM, Mar J, Comas M, Arrospide A, Castells X. Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model. J Neurol Sci. 2016 Jun 15;365:59-64.

Keywords

Acute stroke , Outcomes , Thrombolysis

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026

Implementado por OpenGeek Services